The North American Neuroendocrine Tumor Society (NANETS) will present the NANETS Clinical Investigator Scholarship at the organization’s 10th annual symposium, to be held October 19-21 in Philadelphia, PA.

The NCI Scholarship supports clinical projects as well as the investigator's potential to make future clinical contributions to the neuroendocrine tumor field and is intended to encourage clinicians’ career development in this area of medicine. The scholarship is supported by IPSEN Biopharmaceuticals in memory of Dr Edda Gomez-Panzani, a NET researcher and advocate who dedicated her life to working with those in need. The two-year award provides $50,000 in funding each year, which is directed to the investigator’s sponsoring institution.

NANETS member M. Sue O’Dorisio, MD, PhD, of the University of Iowa Hospitals & Clinics, seeks applicants for two Developmental Research Program awards ($50,000 each) and one Career Enhancement Program award ($100,000). The deadline to apply is Monday, July 17, 2017.

Drew Pardoll, MD, PhD, of Johns Hopkins Medical Institutions, will be presenting the keynote on Friday, October 20 at the 2017 symposium in Philadelphia, Pennsylvania. His topic will be "Harnessing the Patient’s Immune System Against Their Tumor: The Revolution in Cancer Therapy." He observed that the application of 40 years of basic immunology and cancer immunology is now paying off in the establishment of immunotherapy as a new pillar of cancer treatment.